SINO BIOPHARMACEUTICAL-UNADR (SBHMY:OTCMKTS)
$0 None (None%)
Analysed SINO BIOPHARMACEUTICAL-UNADR (SBHMY:OTCMKTS) News Sources
Sanofi bets on Sino Biopharm’s transplant drug in $1.5bn licensing deal
04-03-2026
pharmaceutical-technology.com
Weighing Sino Biopharmaceutical (SEHK:1177) After Strong One Year Share Price Run
16-01-2026
yahoo.com
Phrontline Biopharma Raises $60 Million in Pre-A+ Financing to Advance Global Development of Bispecific and Dual-Payload ADCs
25-11-2025
yahoo.com
MediTrust Health and Sino Biopharm Sign Strategic Cooperation Agreement at CIIE 2025 to Advance Drug-Insurance Integration New Model
10-11-2025
yahoo.com
Merck & Co., Inc., Rahway, N.J., USA Announces Third-Quarter 2025 Financial Results
30-10-2025
yahoo.com
What Do Recent Swings and Cash Flow Growth Mean for Sino Biopharm’s 2025 Value?
19-10-2025
yahoo.com
I-Mab Announces Intention to Undertake Strategic Transformation to Global Biotech Platform, to Pursue Hong Kong IPO, and Rebrand as NovaBridge Biosciences
16-10-2025
yahoo.com
Sino Biopharma spends $951m to acquire China-based LaNova Medicines
15-07-2025
pharmaceutical-technology.com
Cancer drugmaker LaNova to sell to China’s Sino Biopharm
15-07-2025
biopharmadive.com
Global First-in-Class AT2R Antagonist TRD205 Advances to Phase II: First Patient Dosed in Chronic Post-Surgical Neuropathic Pain Trial
05-05-2025
yahoo.com
What is the current price of SINO BIOPHARMACEUTICAL-UNADR (SBHMY:OTCMKTS)?
The current price of SINO BIOPHARMACEUTICAL-UNADR (SBHMY:OTCMKTS) is $0.
SINO BIOPHARMACEUTICAL-UNADR (SBHMY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of SINO BIOPHARMACEUTICAL-UNADR (SBHMY:OTCMKTS) since the previous trading day is $None.
SINO BIOPHARMACEUTICAL-UNADR (SBHMY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of SINO BIOPHARMACEUTICAL-UNADR (SBHMY:OTCMKTS) since the previous trading day is None%.
What is the most recent average sentiment score for SINO BIOPHARMACEUTICAL-UNADR (SBHMY:OTCMKTS)?
The most recent average sentiment score for SINO BIOPHARMACEUTICAL-UNADR (SBHMY:OTCMKTS) is 72 out of 100.
What is the most recent average sentiment for SINO BIOPHARMACEUTICAL-UNADR (SBHMY:OTCMKTS)?
The most recent sentiment for SINO BIOPHARMACEUTICAL-UNADR (SBHMY:OTCMKTS) is .
SEC-8K** Filing Available For SINO BIOPHARMACEUTICAL-UNADR (SBHMY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.